Literature DB >> 19405120

Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles.

Elodie Ristorcelli1, Evelyne Beraud, Sylvie Mathieu, Dominique Lombardo, Alain Verine.   

Abstract

We previously reported that exosomal nanoparticles secreted by human pancreatic tumoral cell lines decrease tumoral cell proliferation through the mitochondria-dependent apoptotic pathway, because of activation of pro-apoptotic phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and of glucose synthase kinase-3beta (GSK-3beta). Interactions between exosomal nanoparticles and cells are thought to involve membrane lipid rafts. However, the underlying mechanism is unknown. Here, we report that the interaction of exosomal nanoparticles with pancreatic cancer cells led to decreased expression of hairy and enhancer-of-split homolog-1 (Hes-1), the intranuclear target of Notch-1 signaling pathway, and to activation of the apoptotic pathway after a cell cycle arrest in G(0)G(1) phase. Strikingly, the expression level of Notch-1 pathway components was critical, because exosomal nanoparticles decreased the proliferation of cells in which these partners are either weakly represented, in differentiated adenocarcinoma cells, or inhibited, in poorly differentiated carcinoma cells, by blocking presenilin in the gamma-secretase complex that regulates the Notch-1 pathway. Overexpression of Notch-1 intracellular domain resulted in the reversion of the cell proliferation inhibition promoted by exosomal nanoparticles. Blocking presenilin unexpectedly resulted in activation of PTEN and GSK-3beta. Conversely, inhibiting either PTEN or GSK-3beta increased Hes-1 expression and partially counteracted the inhibition of proliferation promoted by exosomal nanoparticles, highlighting reciprocal regulations between Notch signaling and PTEN/GSK-3beta. We concluded that interactions of exosomal nanoparticles with target cells, at lipid rafts where Notch-1 pathway partners are localized, hampered the functioning of the Notch-1 survival pathway and activated the apoptotic pathway, which determines tumoral cell fate. 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405120     DOI: 10.1002/ijc.24375

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  52 in total

1.  Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Christopher J Ward; Sergio A Gradilone; Jesus M Banales; Tatyana V Masyuk; Brynn Radtke; Patrick L Splinter; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

Review 2.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 3.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

4.  Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.

Authors:  Gabriel Frampton; Monique Coufal; Huang Li; Jonathan Ramirez; Sharon DeMorrow
Journal:  Exp Cell Res       Date:  2010-03-25       Impact factor: 3.905

5.  Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.

Authors:  Iris R Bell; John A Ives; Wayne B Jonas
Journal:  Dose Response       Date:  2013-11-07       Impact factor: 2.658

6.  Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.

Authors:  Pinar Kanlikilicer; Mohammed H Rashed; Recep Bayraktar; Rahul Mitra; Cristina Ivan; Burcu Aslan; Xinna Zhang; Justyna Filant; Andreia M Silva; Cristian Rodriguez-Aguayo; Emine Bayraktar; Martin Pichler; Bulent Ozpolat; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

Review 7.  Extracellular movement of signaling molecules.

Authors:  Patrick Müller; Alexander F Schier
Journal:  Dev Cell       Date:  2011-07-19       Impact factor: 12.270

Review 8.  Exosomes: Definition, Role in Tumor Development and Clinical Implications.

Authors:  Alberto Carretero-González; Irene Otero; Lucía Carril-Ajuria; Guillermo de Velasco; Luis Manso
Journal:  Cancer Microenviron       Date:  2018-05-03

Review 9.  Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.

Authors:  Asfar S Azmi; Bin Bao; Fazlul H Sarkar
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 10.  Exosomes as potent regulators of HCC malignancy and potential bio-tools in clinical application.

Authors:  Zhen Qu; Chunping Jiang; Junhua Wu; Yitao Ding
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.